Undtagelsesvist kan vaccinen injiceres subkutant hos patienter med thrombocytopeni eller blødningsforstyrrelser.
17 Exceptionally, the vaccine may be administered subcutaneously in patients with thrombocytopoenia or bleeding disorders.